ATC Code C01 - Wikipedia

Jump to content

Contents

move to sidebar hide

• (Top)
• 1 C01A Cardiac glycosides Toggle C01A Cardiac glycosides subsection
  • 1.1 C01AA Digitalis glycosides
  • 1.2 C01AB Scilla glycosides
  • 1.3 C01AC Strophanthus glycosides
  • 1.4 C01AX Other cardiac glycosides
• 2 C01B Antiarrhythmics, class I and III Toggle C01B Antiarrhythmics, class I and III subsection
  • 2.1 C01BA Antiarrhythmics, class Ia
  • 2.2 C01BB Antiarrhythmics, class Ib
  • 2.3 C01BC Antiarrhythmics, class Ic
  • 2.4 C01BD Antiarrhythmics, class III
  • 2.5 C01BG Other antiarrhythmics, class I and III
• 3 C01C Cardiac stimulants excluding cardiac glycosides Toggle C01C Cardiac stimulants excluding cardiac glycosides subsection
  • 3.1 C01CA Adrenergic and dopaminergic agents
  • 3.2 C01CE Phosphodiesterase inhibitors
  • 3.3 C01CX Other cardiac stimulants
• 4 C01D Vasodilators used in cardiac diseases Toggle C01D Vasodilators used in cardiac diseases subsection
  • 4.1 C01DA Organic nitrates
  • 4.2 C01DB Quinolone vasodilators
  • 4.3 C01DX Other vasodilators used in cardiac diseases
• 5 C01E Other cardiac preparations Toggle C01E Other cardiac preparations subsection
  • 5.1 C01EA Prostaglandins
  • 5.2 C01EB Other cardiac preparations
  • 5.3 C01EX Other cardiac combination products
• 6 See also
• 7 References

• Article
• Talk

English

• Read
• Edit
• View history

Tools Tools move to sidebar hide Actions

• Read
• Edit
• View history

General

• What links here
• Related changes
• Upload file
• Permanent link
• Page information
• Cite this page
• Get shortened URL
• Download QR code

Print/export

• Download as PDF
• Printable version

In other projects

• Wikidata item

Appearance move to sidebar hide From Wikipedia, the free encyclopedia Pharmaceutical drug classification

ATC code C01 Cardiac therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C01 is part of the anatomical group C Cardiovascular system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC01.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C01A Cardiac glycosides

[edit]

C01AA Digitalis glycosides

[edit] C01AA01 Acetyldigitoxin C01AA02 Acetyldigoxin C01AA03 Digitalis leaves C01AA04 Digitoxin C01AA05 Digoxin C01AA06 Lanatoside C C01AA07 Deslanoside C01AA08 Metildigoxin C01AA09 Gitoformate C01AA52 Acetyldigoxin, combinations

C01AB Scilla glycosides

[edit] C01AB01 Proscillaridin C01AB51 Proscillaridin, combinations

C01AC Strophanthus glycosides

[edit] C01AC01 G-strophanthin C01AC03 Cymarin

C01AX Other cardiac glycosides

[edit] C01AX02 Peruvoside

C01B Antiarrhythmics, class I and III

[edit]

C01BA Antiarrhythmics, class Ia

[edit] C01BA01 Quinidine C01BA02 Procainamide C01BA03 Disopyramide C01BA04 Sparteine C01BA05 Ajmaline C01BA08 Prajmaline C01BA12 Lorajmine C01BA13 Hydroquinidine C01BA51 Quinidine, combinations excluding psycholeptics C01BA71 Quinidine, combinations with psycholeptics

C01BB Antiarrhythmics, class Ib

[edit] C01BB01 Lidocaine C01BB02 Mexiletine C01BB03 Tocainide C01BB04 Aprindine

C01BC Antiarrhythmics, class Ic

[edit] C01BC03 Propafenone C01BC04 Flecainide C01BC07 Lorcainide C01BC08 Encainide C01BC09 Ethacizine

C01BD Antiarrhythmics, class III

[edit] C01BD01 Amiodarone C01BD02 Bretylium tosilate C01BD03 Bunaftine C01BD04 Dofetilide C01BD05 Ibutilide C01BD06 Tedisamil C01BD07 Dronedarone

C01BG Other antiarrhythmics, class I and III

[edit] C01BG01 Moracizine C01BG07 Cibenzoline C01BG11 Vernakalant

C01C Cardiac stimulants excluding cardiac glycosides

[edit]

C01CA Adrenergic and dopaminergic agents

[edit] C01CA01 Etilefrine C01CA02 Isoprenaline C01CA03 Norepinephrine C01CA04 Dopamine C01CA05 Norfenefrine C01CA06 Phenylephrine C01CA07 Dobutamine C01CA08 Oxedrine C01CA09 Metaraminol C01CA10 Methoxamine C01CA11 Mephentermine C01CA12 Dimetofrine C01CA13 Prenalterol C01CA14 Dopexamine C01CA15 Gepefrine C01CA16 Ibopamine C01CA17 Midodrine C01CA18 Octopamine C01CA19 Fenoldopam C01CA21 Cafedrine C01CA22 Arbutamine C01CA23 Theodrenaline C01CA24 Epinephrine C01CA25 Amezinium metilsulfate C01CA26 Ephedrine C01CA27 Droxidopa C01CA28 Centhaquine C01CA30 Combinations C01CA51 Etilefrine, combinations

C01CE Phosphodiesterase inhibitors

[edit] C01CE01 Amrinone C01CE02 Milrinone C01CE03 Enoximone C01CE04 Bucladesine QC01CE90 Pimobendane

C01CX Other cardiac stimulants

[edit] C01CX06 Angiotensinamide C01CX07 Xamoterol C01CX08 Levosimendan C01CX09 Angiotensin II C01CX10 Omecamtiv mecarbil

C01D Vasodilators used in cardiac diseases

[edit]

C01DA Organic nitrates

[edit] C01DA02 Glyceryl trinitrate C01DA04 Methylpropylpropanediol dinitrate C01DA05 Pentaerithrityl tetranitrate C01DA07 Propatylnitrate C01DA08 Isosorbide dinitrate C01DA09 Trolnitrate C01DA13 Eritrityl tetranitrate C01DA14 Isosorbide mononitrate C01DA20 Organic nitrates in combination C01DA38 Tenitramine C01DA52 Glyceryl trinitrate, combinations C01DA54 Methylpropylpropanediol dinitrate, combinations C01DA55 Pentaerithrityl tetranitrate, combinations C01DA57 Propatylnitrate, combinations C01DA58 Isosorbide dinitrate, combinations C01DA59 Trolnitrate, combinations C01DA63 Eritrityl tetranitrate, combinations C01DA70 Organic nitrates in combination with psycholeptics

C01DB Quinolone vasodilators

[edit] C01DB01 Flosequinan

C01DX Other vasodilators used in cardiac diseases

[edit] C01DX01 Itramin tosilate C01DX02 Prenylamine C01DX03 Oxyfedrine C01DX04 Benziodarone C01DX05 Carbocromen C01DX06 Hexobendine C01DX07 Etafenone C01DX08 Heptaminol C01DX09 Imolamine C01DX10 Dilazep C01DX11 Trapidil C01DX12 Molsidomine C01DX13 Efloxate C01DX14 Cinepazet C01DX15 Cloridarol C01DX16 Nicorandil C01DX18 Linsidomine C01DX19 Nesiritide C01DX21 Serelaxin C01DX22 Vericiguat C01DX51 Itramin tosilate, combinations C01DX52 Prenylamine, combinations C01DX53 Oxyfedrine, combinations C01DX54 Benziodarone, combinations

C01E Other cardiac preparations

[edit]

C01EA Prostaglandins

[edit] C01EA01 Alprostadil

C01EB Other cardiac preparations

[edit] C01EB02 Camphor C01EB03 Indometacin C01EB04 Crataegus glycosides C01EB05 Creatinolfosfate C01EB06 Fosfocreatine C01EB07 Fructose 1,6-diphosphate C01EB09 Ubidecarenone C01EB10 Adenosine C01EB11 Tiracizine C01EB13 Acadesine C01EB15 Trimetazidine C01EB16 Ibuprofen C01EB17 Ivabradine C01EB18 Ranolazine C01EB21 Regadenoson C01EB22 Meldonium C01EB23 Tiazotic acid C01EB24 Mavacamten C01EB25 Acoramidis QC01EB90 Sirolimus

C01EX Other cardiac combination products

[edit]

See also

[edit]

• Class II antiarrhythmics (beta blocking agents) are in the ATC group C07.
• Class IV antiarrhythmics (cardiac calcium channel blockers) are in the ATC group C08D.

References

[edit]

1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. ^ "ATC/DDD Index 2022: code C01". WHO Collaborating Centre for Drug Statistics Methodology.
5. ^ "ATCvet Index 2022: code QC01". WHO Collaborating Centre for Drug Statistics Methodology.

v t e Cardiac glycosides (C01A)
Bufadienolides	Bufo Arenobufagin Bufotalin Cinobufagin Marinobufagin Scilla Proscillaridin Scilliroside Kalanchoe Daigremontianin
Cardenolides	Digitalis Acetyldigitoxin Acetyldigoxin Digitoxin# Digoxin# Lanatoside C Deslanoside Metildigoxin Gitoformate Strophanthus Ouabain (g-Strophanthin) k-Strophanthin Cymarin Thevetia Peruvoside
#WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III

v t e Antiarrhythmic agents (C01B)
Channel blockers	class I(Na+ channel blockers) class Ia (Phase 0→ and Phase 3→) Ajmaline Disopyramide Hydroquinidine Lorajmine Prajmaline Procainamide# Quinidine# Sparteine class Ib (Phase 3←) IV Lidocaine# enteral Aprindine Mexiletine Tocainide class Ic (Phase 0→) Encainide‡ Ethacizine Flecainide Indecainide‡ Lorcainide Moracizine‡ Propafenone class III(Phase 3→, K+ channel blockers) Amiodarone Bretylium Bunaftine Celivarone† Dofetilide Dronedarone E-4031† Ibutilide Nifekalant Sotalol Tedisamil Vernakalant class IV(Phase 4→, Ca2+ channel blockers) Diltiazem Verapamil#
Receptor agonistsand antagonists	class II(Phase 4→, β blockers) Nadolol Pindolol Propranolol cardioselective Acebutolol Atenolol Esmolol Landiolol Metoprolol A1 agonist Adenosine Benzodiazepines Barbiturates M2 muscarinic antagonist: Atropine Disopyramide Quinidinemuscarinic agonist: Digoxin α receptors Amiodarone Bretylium Quinidine Verapamil
Ion transporters	Na+/ K+-ATPase Digitoxin Digoxin Ouabain
#WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III

v t e Cardiac stimulants excluding cardiac glycosides (C01C)
Adrenergic anddopaminergic agents	Adrenergic agonists α Denopamine Metaraminol Methoxamine Midodrine Norfenefrine Oxedrine Phenylephrine β Arbutamine Dobutamine Isoprenaline Prenalterol mixed Amezinium metilsulfate Droxidopa Epinephrine # Etilefrine Norepinephrine Dopamine agonists Fenoldopam Both Docarpamine Dopamine # Dopexamine Ibopamine Octopamine Unknown/ungrouped Cafedrine Dimetofrine Gepefrine Mephentermine Theodrenaline
Phosphodiesterase inhibitors (PDE3I)	Amrinone Bucladesine Enoximone Milrinone Vesnarinone
Other cardiac stimulants	Angiotensinamide Levosimendan Omecamtiv mecarbil Pimobendan Xamoterol
#WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III

v t e Vasodilators used in cardiac diseases (C01D)
Nitrovasodilators	Nitroglycerin # Isosorbide dinitrate # Isosorbide mononitrate Itramin tosilate Linsidomine Molsidomine Nicorandil Pentaerythritol tetranitrate Propatylnitrate Tenitramine Trolnitrate
Quinolone vasodilators	Flosequinan‡
Others	Benziodarone Carbocromen Cinepazet Cloridarol Dilazep Efloxate Etafenone Gapicomine Heptaminol Hexobendine Imolamine Levosimendan Nesiritide Nicorandil Oxyfedrine Pimobendan Prenylamine Serelaxin Trapidil Vericiguat
#WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III

Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_C01&oldid=1264709509" Category:

• ATC codes

Hidden categories:

• Articles with short description
• Short description is different from Wikidata

Search Search Toggle the table of contents ATC code C01 23 languages Add topic